Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. - sprookjes - yvandenbroek - TriplyDB

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

http://www.wikidata.org/entity/Q36583051

about

Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells Cdc25B functions as a novel coactivator for the steroid receptors Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase.Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Regulation of hormonal therapy resistance by cell cycle machinery.Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols.Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis.Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells Tamoxifen-stimulated growth of breast cancer due to p21 loss Estrogen-responsive genes encoding egg yolk proteins vitellogenin and apolipoprotein II in chicken are differentially regulated by selective estrogen receptor modulators.Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.AR, the cell cycle, and prostate cancer.Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.The "busy life" of unliganded estrogen receptors.Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.Synthesis of 4,4'-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity.Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor alpha.MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement.Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein.

P2860

Q24299553-83AA60A0-B130-42A1-8E41-8837D0E382BD Q24548253-40330FFA-E11E-4B43-A8E2-EAC05C38DDBF Q24678662-6A75A31A-B852-4385-A559-D1E2A3ABBCBF Q28139675-5D481D13-81D2-447B-8F31-BB25F949D694 Q28485944-5E88629C-115A-4012-BB59-2B4AAACEB7C1 Q30472059-9A3C0451-413A-4720-95FD-7E2A95EEA26A Q33552193-88C610EF-F4FD-4204-A784-56F3CACCC47A Q33631775-1204780E-9122-4075-92B8-3B7CE3F128B4 Q33635621-2E6CB987-FAFC-4AD2-9929-2E3E4FD7CC22 Q33822845-73BBCBE3-202E-4B57-9512-E6B4A874F02C Q33842800-AAD11663-152F-4D9B-BDD8-322984DF2F3C Q33947274-29914438-AB47-4CFC-A7AC-4619B1E5320C Q34887604-A064DDD4-1AD4-4335-B8D8-477D3FC26C11 Q35558138-7F58EDB9-BFCF-4480-98C4-0021C3CDC3FC Q36423493-422FCCA1-E910-4B34-A98C-6834CB51BBF3 Q36437107-E96C1D57-F275-4A4D-98BC-24548B725956 Q36514584-E4C957DF-3E40-4B27-9BBB-48851AB52DF6 Q37095260-FD7FE51A-195A-4644-8DD0-5779325CF275 Q37383757-C2F39919-6ACA-4D0B-8DD4-AA419F0260CD Q37428211-02C1F00F-01E8-4AAE-ADB3-AF847121A69A Q37851398-D8EEDDF3-1BF8-4E27-83F1-4D5D4B25E218 Q38618003-50C55793-EABB-460F-B95D-A6F5AEB151C6 Q38675849-55775328-271F-4254-85DA-A7D7853A67EA Q38863942-BAC51C91-A1EE-482D-94A6-D336750DAD9A Q38949247-680DC086-87F5-4960-BD09-4FD1B3941DE7 Q40486142-318B5B3C-B9F2-49E2-9581-8F51FBD95526 Q40585585-26DADCE4-D816-463A-ACA6-C6C1886AB473 Q40737595-FFE4F3D5-C1C5-451F-AF56-51EDBE8E98D0 Q41660033-928F398E-9D3D-4C9A-B127-63FD1CC4F540 Q42055276-47D29E93-C54C-4666-992A-C84BF382714F Q44077300-DDAA81D6-D569-4F2F-A5D7-F413908978BE Q46433342-5071F6FE-FA8C-4618-B7ED-3ADE385765B4 Q47842837-CD93D255-2D2B-410E-B914-08214B591EF7

P2860

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

http://www.wikidata.org/entity/Q36583051

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@ast

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@en

type

label

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@ast

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@en

prefLabel

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@ast

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@en

P1433

Q36583051-892D7AA1-4346-4F63-9D61-B17BA42A28BA

P1476

Q36583051-A186038E-4EC6-49E8-BF46-C367A2EB47EB

P2093

Q36583051-71C44664-D5A2-40A2-8BC4-42539D24A46F

Q36583051-E37E9BAF-4649-49D1-93B4-97BCA256B4C0

Q36583051-F006FA91-53B6-44B9-9C30-E94A714054DC

P2860

Q36583051-0184C964-A38E-47A6-88D4-7942F7C6BE6C

Q36583051-0E331FCC-F127-4B10-A1AB-94F1F3125B89

Q36583051-34FFE3A8-F36E-48EA-9976-C8B0EF137D98

Q36583051-379B46C3-35E9-45E0-8D8F-6AB16E965B0D

Q36583051-41253F93-7AF3-455F-9B06-296423B55B1A

Q36583051-4AE49895-081E-4A6C-BF4A-8359ABAFCCAF

Q36583051-4EB5A38A-FEB1-4CE6-8B55-DDE431B90CC2

Q36583051-523A4C55-512A-43B7-8497-2315ABAB5F9A

Q36583051-6CFF8518-A61D-4EF4-9021-3CAB9ACC1311

Q36583051-6F9A9F06-9772-4099-8C98-CABFC007FBDF

P304

Q36583051-01009E4D-5BBC-4780-B769-339D4452690A

P31

Q36583051-ED860554-3ADD-4F9D-9514-82E29050EF1E

P356

Q36583051-7F457199-8305-425E-AAFE-4EE44B446C73

P407

Q36583051-5D4079DC-5506-4404-8A03-FD38754CC805

P433

Q36583051-C4C389F2-1ACE-4DD2-9AA4-ABA854D06797

P478

Q36583051-58EC176D-D69D-4033-AB4F-0AAC2880F801

P577

Q36583051-1C74CB03-8F21-4CDF-885C-30269171CEA6

P5875

Q36583051-1FD09BD9-F312-4AF0-BDAD-45528A3137D9

P698

Q36583051-F2511EB5-9564-4284-9C53-9F999AF5D37B

P932

Q36583051-37143B80-954E-4A5B-884C-B6F710BD18C9

P356

PNAS.94.19.10132

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

@en

P2093

Garabedian MJ

http://www.w3.org/2001/XMLSchema#string

Rogatsky I

http://www.w3.org/2001/XMLSchema#string

Trowbridge JM

http://www.w3.org/2001/XMLSchema#string

P2860

Cdk-activating kinase complex is a component of human transcription factor TFIIH

Human cyclin-dependent kinase-activating kinase exists in three distinct complexes

New functional activities for the p21 family of CDK inhibitors

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Structure and cell cycle-regulated transcription of the human cyclin A gene

MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH

Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer

CDK-independent activation of estrogen receptor by cyclin D1

Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

P304

10132-10137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.19.10132

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13927383

http://www.w3.org/2001/XMLSchema#string

P698

9294175

http://www.w3.org/2001/XMLSchema#string

P932

23327

http://www.w3.org/2001/XMLSchema#string